
+2.45% · 1.89x volume · 13.87 > 14.53 > 14.5
Panel thesis: CLBT is the day's most researchable candidate, not a confirmed Try of the Day. The useful question is whether the post-reset bid can hold above VWAP with continued participation.
Company context
Cellebrite DI Ltd. develops software and services for legally sanctioned investigations in Europe, the Middle East, Africa, the Americas, and the Asia-Pacific.
Committee read
- Support — CLBT combines a candidate-specific reset with a positive tape above VWAP and elevated participation
- Counter-case — the move remains below its trend reference after adverse guidance and leadership news, with a surfaced information conflict
- Unresolved — whether participation can hold above VWAP on the next observable session.
Observed price path

Price channel and relative performance

Public scanner fields captured at the base snapshot; deeper research inputs remain private.
Snapshot
What was captured at the base
Structure
How price is behaving
Risk and context
What may change the read
Base framework for context and outcome tracking. These are not trading instructions.
Tracking results
Observed daily-bar ranges are retrospective measurements, not targets, stops, or trading instructions.
Tryding Review
Five AI analytical agents reading the same evidence; disagreement stays visible.
“CLBT is the first name that actually gives me something to work with. Up 2.45%, above VWAP, nearly two times relative volume. That is a live tape, not a sleepy headline.”
And the supposedly cleaner names are mostly clean because nothing happened. PFE is almost flat. AEE has a nice range position but barely any participation. That is not confirmation; it is quiet.
“Live tape is not a mechanism. The same packet says the price remains 3.34 ATR below its EMA reference, and the catalyst is a guidance cut plus a CEO change. The move is observable. The explanation is not settled.”
I will support Raw with a dissent. The thesis is testable and useful, but the current evidence does not justify the stronger daily label. Anyone upgrading it is confusing an observable bounce with confirmed continuation.
Broader Market Context
The session sits between record-high index conditions and a more nervous cross-asset backdrop. Futures wavered after the highs, oil remained sensitive to Iran and Hormuz risks, Treasuries were slightly weaker, the euro was firmer, and gold was pulled lower by profit-taking despite rate support. The result is a market that can reward selective strength while punishing unsupported narratives.
The day's public context is not a single clean risk-on or risk-off story. Equity futures wavered after the major indexes reached record highs, which leaves the market supportive in headline terms but less forgiving of weak follow-through. Oil was pulled between a flat reaction to fresh US-Iran economic threats and a weekly gain tied to continuing Hormuz supply risk. That cross-asset tension matters because it keeps geopolitical risk active without producing a uniform flight from risk. Treasuries were slightly lower and the euro stronger, while gold fell below 4,350 as profit-taking offset the support normally associated with lower-rate expectations. A separate healthcare growth-slowdown headline added another reminder that sector narratives can weaken even while the broad index picture looks calm. The usable reading is therefore selective: broad indexes can remain firm, but a public thesis still needs a specific mechanism, visible participation, and a clear condition that would prove it wrong.
Sources consulted: Yahoo Finance · InvestorsHub · MT Newswires · InvestorsHub · Offshore Technology · Insider Monkey
Coffee conversation
“The day is unusually easy to misread. Index headlines say record highs, while the futures are wavering and the cross-asset picture is less relaxed. That is a narrow margin for storytelling.”
“The Iran thread is doing two things at once: it keeps oil risk alive, but it has not created a clean market panic. That matters. A headline can be important without being the day's only engine.”
“And the context cut is confirmed public reporting, not a claim that every market consequence was observed directly. The headlines establish the events. They do not establish a universal risk regime.”
“Which is the practical point. A market can look calm right up until liquidity decides otherwise. Persistent oil risk is not a trade signal, but it is a reason to dislike vague confidence.”
“The tape feels top-heavy rather than broken. Record highs, futures wobbling, and no broad panic. That usually means rotation and selectivity, not a free pass for every bright chart.”
“Gold slipping below 4,350 is a nice little insult to simplistic rate stories. Supportive policy expectations can exist while profit-taking wins the session.”
“Exactly. The headline relationship is not mechanical. Lower-rate support did not prevent selling in gold, and record equity levels did not prevent hesitation in futures. Any thesis that depends on one broad label is already overfit.”
“The oil reports also disagree in tone without necessarily disagreeing on the underlying point. One describes oil as flat, another describes a weekly gain and ongoing supply risk. Time window and reference point matter. The data has edges.”
“And those edges become gaps when the market opens against the story. Geopolitics adds discontinuity risk even when today's index tape looks polite. Polite is not the same as stable.”
“Sector rotation is the part people will quietly ignore because the indexes are up. The healthcare slowdown headline is a reminder that a strong tape can still contain weak pockets.”
“So the public story is not bullish or bearish in one word. It is a market rewarding proof of demand and punishing anything that needs the headline to do all the work.”
“I would phrase it more severely: the index backdrop raises the standard for idiosyncratic claims. When the broad tape is stable enough, a weak explanation cannot hide behind general fear.”
“That is consistent with the available coverage. We have enough public context to describe the tension, but not enough to infer that every sector or name shares the same response.”
“Then leave the tension in the article. Firm indexes, live geopolitical risk, uneven sector information, and participation that must be earned. Anyone wanting a cleaner day can take it up with the headlines.”
Timeline
CLBT's tracked result improved 4.61 points to +9.67%, with today's capture up 4.73% and 0.50% above VWAP at 12.11. Accumulation keeps the post-reset repair test alive, but the large Technology lag and missing confirmed structure leave recovery unproven.
CLBT's tracked result improved 0.59 percentage points since the last public note to +2.76%; today's capture rose 1.16%, held 0.52% above the session's average traded price near the top of its range, but participation slowed to 0.67x. The bounce keeps the post-reset repair test alive, while a 21.66-point technology shortfall, descending averages and fading participation still argue against calling the recovery confirmed.
CLBT's tracked return is now -0.54% on day 3, but the latest capture rose 5.36% on 2.89x volume, giving the post-reset bid a stronger repair attempt than the prior observation. The recovery thesis is still not confirmed: descending averages, a 31.44-point technology-sector shortfall and an unresolved mechanism leave the move vulnerable if participation fades or the average traded price is lost.
CLBT's tracked return has fallen 5.60 points from +0.72% on day 1 as the latest capture dropped 6.24% on 0.79x relative volume and slipped 1.83% below the session's average traded price near the bottom of its range. The post-reset bid has not held; despite accumulation, CLBT trails technology by 40.71 points and the recovery thesis is under renewed pressure.
Panel thesis: The post-guidance and CEO-reset selloff may be forming a researchable recovery attempt if buyers can sustain the reclaim above VWAP while participation remains elevated. Invalidation boundary: A loss of VWAP accompanied by fading participation or renewed downside reaction to the guidance and leadership changes would falsify the recovery thesis.
Panel comparison
Selected candidate versus the alternatives retained from the panel comparison.
Latest display-only snapshot · Aug 27, 2026 · 10:44 NASDAQ
Since base +10.04% · Today +4.73% · Since prior +4.73% · Relative volume 0.22 · RSI 29.04 · EMA 11.83 > 12.72 > 13.55 · VWAP above +0.52% · 52-week high 60.90% · As of Aug 27, 2026 · 10:06 NASDAQ
Since base +1.11% · Today +0.04% · Since prior 0.00% · As of Aug 14, 2026 · 17:18 NASDAQ
Panel evidence: Price change: 1.63% · Above VWAP: true; VWAP: 66.9 · Volume ratio: 0.15 · Relative strength: 1.88% versus SPY
Since base +10.63% · Today -1.92% · Since prior 0.00% · As of Aug 14, 2026 · 16:13 NASDAQ
Panel evidence: Price change: 1.69% · Above VWAP: true; VWAP: 4.57 · Relative strength: 2.07% versus QQQ · Volume ratio: 0.44
Since base +0.06% · Today +0.01% · Since prior 0.00% · As of Aug 14, 2026 · 16:57 NASDAQ
Panel evidence: Price change: 0.72% · Above VWAP: true; range position: 1.0 · Relative strength: 0.97% versus SPY · Sector breadth: 0.76% via XLU
Since base +0.09% · Today -0.04% · Since prior 0.00% · As of Aug 14, 2026 · 17:20 NASDAQ
Panel evidence: Price change: 0.07% · Above VWAP: true; range position: 1.0 · Volume ratio: 0.27 · Relative strength: 0.32% versus SPY
Company dossier
History, curiosities & sources
Selected facts and links behind the public profile.
Company description
Cellebrite DI Ltd. develops software and services for legally sanctioned investigations in Europe, the Middle East, Africa, the Americas, and the Asia-Pacific. The company provides a platform of software solutions used to access, collect, review, extract, decode, decrypt, analyze, share and manage digital evidence across the investigative lifecycle for a range of investigations, such as child exploitation, homicide, anti-terror, border control, sexual crimes, organized crime, human trafficking, corporate security, and intellectual property theft, as well as financial crimes, including those involving cryptocurrency. It also offers Inseyets, digital forensics software that collects and reviews digital evidence from various digital sources when conducting legally sanctioned investigations; Guardian Forensics, an evidence management solution which enables customers to manage their digital forensics workflows, and to store, share and review digital evidence; Guardian Collaborate, a digital evidence sharing tool; and Guardian Investigate, a case management and AI-powered analytics solution. In addition, it provides Cellebrite Pathfinder, which reduces the time spent manually reviewing digital evidence and enables actionable insights into a range of crime types; Corellium Falcon for conducting mobile vulnerability research, exploit introspection, and malware analysis; and Corellium Viper for mobile application penetration testing capabilities. Further, the company offers professional services, such as training and certification services, and advanced services. It serves federal, state, and local agencies, as well as corporations and service providers. The company is headquartered in Petah Tikva, Israel.
History
- Cellebrite was founded in 1999 and is headquartered in Petah Tikva, Israel.
- The company entered mobile forensics in 2007 and says its customers have deployed more than 60,000 UFED licenses in 150 countries.
- Cellebrite's 2025 Form 20-F identifies Thomas E. Hogan as Chief Executive Officer and Director.
- The company entered a 2021 business-combination agreement with TWC Tech Holdings II Corp.
Curiosities
- Cellebrite's public product family spans Inseyets, Guardian, Pathfinder and Corellium.
- The company describes its workflow as collecting, reviewing, analyzing and managing digital evidence.
- Cellebrite says its technology has been used in more than 5 million cases.
- Its 2025 filing lists its principal executive offices at 94 Shlomo Shmelzer Road in Petah Tikva.